Durect Corp.
Specialty pharmaceutical company developing innovative drugs for pain and chronic diseases, with late-stage development. Learn more
Launch date
Employees
Market cap
€42.9m
Enterprise valuation
€43m (Public information from Sep 2024)
Share price
$1.37 DRRX
Cupertino California (HQ)
Authorizing premium user...